• LAST PRICE
    0.7500
  • TODAY'S CHANGE (%)
    Trending Down-0.0431 (-5.4344%)
  • Bid / Lots
    0.7302/ 12
  • Ask / Lots
    0.8491/ 1
  • Open / Previous Close
    0.7700 / 0.7931
  • Day Range
    Low 0.7300
    High 0.8000
  • 52 Week Range
    Low 0.5388
    High 1.3800
  • Volume
    141,291
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 0.7931
TimeVolumeALGS
09:32 ET50060.77
09:38 ET1000.7956
09:39 ET1000.7956
09:45 ET2500.7931
09:48 ET24000.7955
09:57 ET1580.7852
09:59 ET1000.7905
10:03 ET10000.78545
10:06 ET10500.78505
10:12 ET2000.79
10:28 ET1000.7767
10:30 ET13070.7701
10:35 ET1000.784575
10:37 ET1000.7899
10:46 ET9960.781
10:50 ET36000.7704
10:55 ET59000.785
10:57 ET1000.7851
11:00 ET1000.7843
11:02 ET1000.7851
11:04 ET2000.7854
11:06 ET1000.7854
11:08 ET4000.77775
11:42 ET1000.7854
11:54 ET3960.771
11:56 ET3500.772
12:02 ET1000.7799
12:05 ET13000.77
12:07 ET1000.77015
12:21 ET7000.77
12:34 ET1000.7696
12:48 ET1000.77
12:50 ET2000.7604
12:52 ET2000.76515
12:54 ET1000.76515
12:56 ET1000.76515
12:57 ET2000.7699
01:14 ET25000.7702
01:15 ET54000.7725
01:17 ET11000.7725
01:21 ET2000.7793
01:24 ET2300.7725
01:28 ET1000.7788
01:35 ET2000.765
01:37 ET1000.7789
01:42 ET1000.77245
01:44 ET1000.77245
01:51 ET2000.7727
02:27 ET3000.77255
02:38 ET26500.7727
02:44 ET1000.7788
02:45 ET22000.77255
02:47 ET3000.7726
02:51 ET1450.765959
02:54 ET1000.7788
02:58 ET1300.7798
03:00 ET1000.7787
03:03 ET1000.7799
03:05 ET2000.7799
03:07 ET1000.7726
03:12 ET1000.78
03:14 ET1000.7799
03:16 ET2000.7799
03:18 ET81420.7604
03:20 ET12000.7604
03:23 ET6000.7697
03:25 ET3000.76965
03:27 ET2000.7784
03:30 ET3000.7727
03:32 ET3000.7752
03:34 ET4000.7766
03:36 ET2000.7789
03:38 ET2000.7789
03:39 ET2000.7787
03:41 ET1000.7789
03:43 ET2000.7791
03:45 ET4000.7699
03:48 ET2000.7786
03:50 ET3000.7782
03:52 ET4000.7766
03:54 ET6000.7736
03:56 ET5000.7772
03:57 ET234720.7515
03:59 ET475360.75
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesALGS
Aligos Therapeutics Inc
60.0M
-0.4x
---
United StatesGRTS
Gritstone bio Inc
78.8M
-0.5x
---
United StatesCELU
Celularity Inc
69.9M
-0.3x
---
United StatesTSBX
Turnstone Biologics Corp
62.6M
-1.0x
---
United StatesCLGN
Collplant Biotechnologies Ltd
59.8M
-8.2x
---
United StatesICCC
ImmuCell Corp
39.1M
-6.7x
---
As of 2024-04-20

Company Information

Aligos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases. The Company discovers and develops therapeutics for metabolic dysfunction associated steatohepatitis (MASH) and viruses with high unmet medical need, such as chronic hepatitis B (CHB) and coronaviruses. Its advanced drug candidate for MASH is ALG-055009, a small molecule thyroid hormone receptor beta (THR-ß) agonist. It is also progressing oligonucleotide projects for MASH. It is developing a portfolio of differentiated CHB drug candidates, including a small molecule Capsid Assembly Modulator that results in the production of empty viral capsids (CAM-E) and small molecule inhibitors of the Programmed Cell Death Ligand 1 (PD-1/PD-L1) interaction. Its third area of focus is to develop drug candidates with pan-coronavirus antiviral activity. Its pipeline includes ALG-055009, ALG-000184, ALG-125755, and ALG-097558.

Contact Information

Headquarters
One Corporate Dr., 2nd Floor, 2nd FloorSOUTH SAN FRANCISCO, CA, United States 94080
Phone
302-658-7581
Fax
302-655-5049

Executives

Chairman of the Board, Chief Executive Officer
Lawrence Blatt
Chief Financial Officer, Executive Vice President
Lesley Calhoun
Executive Vice President, Chief Scientific Officer
Julian Symons
Executive Vice President, Chief Business Officer, General Counsel
Lucinda Quan
Executive Vice President, Chief Medical Officer
Matthew Mcclure

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$60.0M
Revenue (TTM)
$15.5M
Shares Outstanding
75.7M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
2.35
EPS
$-1.82
Book Value
$1.22
P/E Ratio
-0.4x
Price/Sales (TTM)
3.9
Price/Cash Flow (TTM)
---
Operating Margin
-567.50%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.